Unique Class of Drugs Shows Potential in Treating Idiopathic Pulmonary Fibrosis
According to a story from Medical Xpress, a collaborative team of scientists from UT Health San Antonio, the Mayo Clinic, and the Wake Forest School of Medicine, have recently released…